Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease.

MLA

Raman, Maitreyi, et al. “Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans with Nonalcoholic Fatty Liver Disease.” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, vol. 11, no. 7, July 2013, p. 868. EBSCOhost, https://doi.org/10.1016/j.cgh.2013.02.015.

APA

Raman, M., Ahmed, I., Gillevet, P. M., Probert, C. S., Ratcliffe, N. M., Smith, S., Greenwood, R., Sikaroodi, M., Lam, V., Crotty, P., Bailey, J., Myers, R. P., & Rioux, K. P. (2013). Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, 11(7), 868. https://doi.org/10.1016/j.cgh.2013.02.015

Chicago

Raman, Maitreyi, Iftikhar Ahmed, Patrick M Gillevet, Chris S Probert, Norman M Ratcliffe, Steve Smith, Rosemary Greenwood, et al. 2013. “Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans with Nonalcoholic Fatty Liver Disease.” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 11 (7): 868. doi:10.1016/j.cgh.2013.02.015.